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Abstract Ca2+ channel auxiliary L subunits have been shown to
modulate voltage-dependent inactivation of various types of Ca2+
channels. The L1 and L2 subunits, that are differentially
expressed with the L-type K1 Ca2+ channel subunit in heart,
muscle and brain, can specifically modulate the Ca2+-dependent
inactivation kinetics. Their expression in Xenopus oocytes with
the K1C subunit leads, in both cases, to biphasic Ca2+ current
decays, the second phase being markedly slowed by expression of
the L2 subunit. Using a series of L subunit deletion mutants and
chimeric constructs of L1 and L2 subunits, we show that the
inhibitory site located on the amino-terminal region of the L2a
subunit is the major element of this regulation. These results thus
suggest that different splice variants of the L2 subunit can
modulate, in a specific way, the Ca2+ entry through L-type Ca2+
channels in different brain or heart regions.
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1. Introduction
L-type dihydropyridine (DHP)-sensitive Ca2 channels rep-
resent the major pathway for voltage-gated Ca2 entry into
cardiac and smooth muscle cells [1]. In these cells, a rise in
intracellular Ca2 inactivates the L-type channel, thus provid-
ing a control for the Ca2 in£ux through a negative feedback
mechanism [2]. This so-called Ca-dependent inactivation [3^5]
is only recorded on L-type DHP-sensitive Ca2 channels and
is an important regulatory factor for Ca2-activated processes
such as excitation-contraction coupling [6]. Other types of
Ca2 channels are inactivated through di¡erent, voltage-de-
pendent, mechanisms. Cardiac and vascular L-type Ca2
channels consist of a main pore-forming subunit encoded by
di¡erent isoforms of the same K1C gene [7,8]. This K1C subunit
also contains the DHP binding site [9^11] and is associated
with at least two other regulatory subunits: K2-N and L.
Whereas three K2-N genes are known, four di¡erent L subunits
exist of which L1, L2 and L3 have been shown to be expressed
in heart and smooth muscle [12,13]. Biochemical and func-
tional studies have shown that association between the K1C
and the L subunits occurs on speci¢c domains of these sub-
units [14,15]. This association, as is the case for other K1
subunits, induced a profound functional alteration of the L-
type channel in a L subunit isoform-speci¢c manner. There-
fore, speci¢c combinations of the same K1C subunit with dif-
ferent L subunits are expected to have important consequences
on the kinetics and the voltage-dependency of Ca2 entry in
vivo.
When expressed in an heterologous system such as the Xe-
nopus laevis oocyte, the K1C subunit gives rise to Ca2 current
kinetics with a pronounced Ca2-dependent inactivation
[16,17]. The molecular structures responsible for this type of
inactivation were suspected to reside on the K1C subunit itself
[16]. Accordingly, several recent studies have located, on the
carboxy-terminal tail of the K1C subunit, a putative Ca2
binding site and other sequences important for this type of
inactivation [18,19]. The in£uence of the auxiliary L subunit
on the Ca2-dependent inactivation has only recently been
tested [20] and it has been suggested that the same molecular
determinants a¡ect both voltage- and Ca2-dependent inacti-
vation. We have recently shown that the amino-terminal tail
of the rat L2a subunit is directly involved in the slowing e¡ect
of this subunit on both types of inactivation [20]. Since di¡er-
ent splice variants of the L2a subunit exist, not only on this tail
but also on the central region of the subunit [8], we have
tested the involvement of other sequences of the L subunits
in the regulation of Ca2-dependent inactivation. 10 deletions
and ¢ve chimeras of the L1 and L2 subunits have been used.
Here, we report that rapidly or slowly decaying Ca2 cur-
rents can be recorded by co-expression of the K1C subunit with
the L1 or L2 subunit, respectively. Slowing of inactivation is
exclusively due to the presence of the short stretch of amino
acids located on the amino-terminal tail of the L2a subunit, the
central or carboxy-terminal sequence of the subunit being of
minor importance. Our data suggest that the speci¢c splice
variants of the L subunit that composed the L-type Ca2
channels are one of the critical factors regulating Ca2 entry
into muscle cells and neurons [8].
2. Materials and methods
2.1. Construction of deleted and chimeric L subunits
The following calcium channel subunits were used: K1C [21] and K2-
N [21], L1b [22], L2a [23]. All these subunit cDNAs were inserted into
the pMT2 expression vector [21].
2.1.1. Deleted mutants of the L subunit. L1 -TF1-4 and L2 -TF1-4
were constructed by PCR. The sense primer was engineered to possess
an EcoRI site (italic) and a start codon (bold) when necessary. In the
reverse primer, an XbaI site (preceded by a stop codon in the case of
the TF4 subunits) was added at the 5P end. Numbers in parentheses
correspond to the position of the primer in the sequence. GenBank
accession numbers: L1b, X61394 and L2a, M80545. All sequences are
given in the 5P-3P orientation.
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L1-TF1: sense primer EcoRI-ATG-(235^257), antisense primer
XbaI-(1837^1857).
L1-TF2: sense primer EcoRI-ATG-(559^579), antisense primer
identical to L1-TF1.
L1-TF3: sense primer EcoRI-ATG-(706^726), antisense primer
identical to L1-TF1.
L1-TF4: sense primer EcoRI-(64^84), antisense primer XbaI-TCA-
(1317^1298).
L2-TF1: sense primer EcoRI-ATG-(424^444), antisense primer
XbaI-(2168^2190).
L2-TF2: sense primer EcoRI-ATG-(748^769), antisense primer
identical to L2-TF1.
L2-TF3: sense primer EcoRI-ATG-(1009^1031), antisense primer
identical to L2-TF1.
L2-TF4: sense primer EcoRI-(115^133), antisense primer XbaI-
TCA-(1623^1600).
The PCR product was checked and puri¢ed on an agarose gel.
2.1.2. L Chimera. The chimera were obtained by a PCR strategy
as described [24] using the Expand High Fidelity PCR System from
Boehringer Mannheim.
The N-terminal fragments were ampli¢ed using the following prim-
ers:
L-CH1: sense primer identical to L2-TF4; reverse primer: (559^
576 L1b+731^747 L2a).
L-CH2: sense primer identical to L2-TF4; reverse primer: (706^
723 L1b+878^894 L2a).
L-CH3: sense primer identical to L2-TF4; reverse primer: (706^
724 L1b+993^1008 L2a).
L-CH4: sense primer identical to L2-TF4; reverse primer: (235^
249 L1b+409^423 L2a).
The C-terminal fragments were ampli¢ed using the following prim-
ers:
L-CH1: sense primer: (731^747 L2a+559^576 L1b) ; reverse primer
identical to L1-TF1.
L-CH2: sense primer: (878^894 L2a+706^723 L1b) ; reverse primer
identical to L1-TF1.
L-CH3: sense primer: (993^1008 L2a+706^724 L1b) ; reverse primer
identical to L1-TF1.
L-CH4: sense primer: (407^423 L2a+235^249 L1b) ; reverse primer
identical to L1-TF1.
All PCR products were separated on a 1% agarose gel, cut out and
puri¢ed. A second PCR was performed using these products to pro-
duce the ¢nal chimeras. L-truncated forms and L chimera were ¢nally
digested using EcoRI and XbaI, sub-cloned into pBluescript (Strata-
gene) for sequencing (DiDeoxy Terminator technology, Applied Bio-
system) and subsequently into pMT2 for injection and expression (see
[17,25] for details on Xenopus oocytes preparation and injection). 10^
20 nl of a mixture of K1C and L subunits cDNA (concentration 1 Wg/
Wl) was injected in oocytes. In Fig. 2 and 3, the K2-N subunit was co-
injected. No signi¢cant changes in inactivation kinetics were noticed
between K1C+L+K2-N and K1C+L.
2.2. Currents recording and analysis
Whole cell Ba2 currents were recorded under a two electrodes
voltage clamp using the GeneClamp 500 ampli¢er (Axon, Foster
city, CA, USA). The current and voltage electrode (less than 1 M6)
were ¢lled with CsCl, 2.8 M; 1,2-bis(2-aminophenoxy)-ethane-
N,N,N’,N’-tetraacetic acid (BAPTA), 10 mM, pH = 7.2, with CsOH.
Ba2 and Ca2 current recordings were performed after injection of
BAPTA (one or two 40^70 ms injections at 1 bar of (in mM): BAP-
TA-free acid (Sigma), 100; CsOH, 10; N-(2-hydroxyethyl)piperazine-
N’-(2-ethanesulfonic acid) (HEPES), 10, pH 7.2, see [17]). The record-
ing solution had the following composition (in mM): BaOH/CaOH,
10; tetra-ethyl ammonium hydroxide (TEAOH), 20; N-methyl-D-gluc-
amine (NMDG), 50; CsOH, 2; HEPES, 10, pH 7.2, with methane-
sulfonic acid. Currents were ¢ltered and digitized using a DMA-Tec-
mar labmaster and subsequently stored on a IPC 486 personal com-
puter by using the version 6.02 of the pClamp software (Axon). Under
these conditions, the Ca2 currents can be recorded without contam-
ination by the endogenous Ca2-activated Cl3 current (see [14]). Cur-
rents were recorded during a typical test pulse from 380 mV to +10
mV of 2.5 s duration. All currents analyzed in this work had an
amplitude in the range of 0.2^3 WA, when recorded 1^4 days after
injections. Such currents could be repeatedly recorded with all the
combinations of subunits tested. Measurements of the current ampli-
tude and determination of inactivation time constants were performed
using Clamp¢t (pClamp version 6.02, Axon). Inactivation was quan-
ti¢ed by dividing the current measured at the end of a typical test
pulse of +10 mV (2.5 s duration) by the peak amplitude (residual
current in Fig. 2 and 3). All values are presented as mean þ S.E.M.
(number of experminents).
3. Results
Fig. 1A shows typical current traces recorded during volt-
age steps from 380 mV to +10 mV (2.5 s duration), applied to
a voltage-clamped oocyte expressing the rat L-type K1C Ca2
channel subunit in combination with either the L1 or the L2
subunits. In the presence of Ba2 (traces labelled Ba), the L-
type K1C Ca2 channels inactivated with a mono-exponential
time course, whether the L1 or the L2 subunit was expressed
(with respective time constants of 1780 þ 744 ms, n = 15 and
3723 þ 873 ms, n = 3). Therefore, very little voltage-dependent
inactivation was observed with both subunit combinations
under these conditions. Replacing the permeant ion Ba2 by
Ca2 induced, with both subunit combinations, a marked ac-
celeration of the decaying phase of the current (Fig. 1A, traces
labelled Ca), suggesting that both L subunits can interact with
the K1C subunit and regulate the Ca2-dependent inactivation.
Kinetic analysis of these currents show that, in the presence
of Ca2, the decaying phase of the currents required two
exponential phases to be well-described. For the two com-
binations, the fast and slow time constants (d1 and d2)
were both di¡erent from the slow time constant recorded
in Ba2, thus suggesting that they both re£ect a Ca2-depend-
ent process. Interestingly, Ca2 currents £owing through
the K1C+L1 combination inactivated signi¢cantly faster
than the corresponding currents £owing through K1C+L2
channels (Fig. 1A, top right panel), leading to a global
decrease in the amount of Ca2 entering the cells of about
50%.
Comparison of the traces recorded with the two L subunits
at di¡erent voltages showed that expression of the L2 subunit
induced a delayed inactivation, with the initial phase of cur-
rent decay being almost unchanged (see Fig. 1B). At all vol-
tages, d1, the fast time constant of inactivation, was not modi-
¢ed when the K1C subunit was expressed either with the L1 or
the L2 subunit, while d2, the slow time constant of inactiva-
tion, was signi¢cantly increased by expression of the L2 sub-
unit (Fig. 1B). This change in d2 was not due to a modi¢ca-
tion in the level of expression since currents of similar
amplitudes were recorded on oocytes expressing either
K1C+L1 or K1C+L2 subunits combinations (3358 þ 245 nA
and 3324 þ 188 nA, respectively). Interestingly, d1 and d2
were only poorly dependent on the voltage (right panel of
Fig. 1B) and the L2 subunit-induced increase of d2 was present
at all voltages tested. We concluded that the Ca2-dependent
inactivation of the K1C subunit, and therefore the level of
Ca2 entry, can be regulated by expression of di¡erent L sub-
units.
To understand the mechanisms underlying this regulation
and to identify their molecular determinant, we have con-
structed a series of deleted and chimeric forms of the L1
and L2 subunits and analyzed their e¡ect on Ca2-dependent
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inactivation after expression in oocytes with the K1C subunit.
The four L subunit genes are constructed around two con-
served domains (called C1 and C2, white boxes in Fig. 2),
surrounded with variable amino (V1), central (V2) and car-
boxy domains (V3, see shaded boxes in Fig. 2), where alter-
native splicing occurred ([8]). Our ¢rst deletions (TF1, see Fig.
2) removed the variable amino-terminal domains of the two
L subunits. When made on L1, this deletion did not a¡ect the
kinetics of the currents recorded during a typical test pulse of
+10 mV from a holding potential of 380 mV (compare traces
marked L1 and L1TF1 in part A and I2/I1 in part B of Fig. 2),
suggesting that these amino acids are not crucial in setting the
rate at which the K1C+L1 Ca2 channels inactivate in the
presence of Ca2. Expression of larger deletions in the amino
(see traces labelled L1-TF2, L1-TF3 in Fig. 2) or carboxy (L1-
TF4) tails of the L1 subunit, which removed domains V1+C1,
V1+C1+V2 or V3 of the L subunit, respectively, with the K1C
subunit, were also without an e¡ect on the kinetics of the
corresponding Ca2 currents, suggesting that the second con-
served domain, C2, where association with the K1C subunit
occurred, is the only element regulating the e¡ects of the L1
subunit on L-type Ca2 channel inactivation. This was con-
¢rmed by expression of this C2 domain alone (L1-TF7) with
the K1C subunit. This subunit combination did not show any
signi¢cant di¡erence in the rate of Ca2-dependent inactiva-
tion (as measured by the I2/I1 ratio) when compared to the
full length L1 subunit (see Fig. 2).
Di¡erent results were obtained, however, when these dele-
tions were made on the L2 subunit. Co-expression of the ¢rst
deletions, L2-TF1, with the K1C subunit produced functional
Ca2 channels that displayed a typical Ca2-dependent inac-
tivation. However, the kinetics of these currents were signi¢-
cantly faster than those observed when the full length L2 sub-
unit was expressed (Fig. 2). In this case, current traces
recorded with L2-TF1 were very similar to those recorded
Fig. 2. Current traces and Ca2-dependent inactivation, recorded
for di¡erent truncated L1 and L2 subunits. A: Schematic representa-
tion of di¡erent truncated forms of the L1 and L2 subunits and as-
sociated current traces recorded after their expression in oocytes
with the K1C subunit. Sizes of the deletions are marked by an ar-
row. TF0, full length L subunit; TF1, deletion of the ¢rst variable
domain; TF2, deletion of the ¢rst variable and the ¢rst conserved
domains; TF3, deletions up to the second conserved domain; TF4,
deletion of the carboxy variable domain. Currents were recorded
during depolarisations to +10 mV from 380 mV (duration of 2.5
s). B: Average inactivation calculated from traces similar to those
shown in A for the di¡erent truncated L subunits. Inactivation was
quanti¢ed by dividing the current recorded at the end of the depola-
rizing pulse by the peak current (residual current). n = 12, 5, 5, 3, 3
and 9 for L1-TF0, -TF1, -TF2, -TF3, -TF4 and -TF7 and n = 4, 8,
5, 7, 4, 4 and 2 for L2-TF0, -TF1, -TF2, -TF3, -TF4 and -TF7, re-
spectively.
Fig. 1. K1C+L1 or K1C+L2 Ca2 currents display di¡erent inactiva-
tion kinetics. A: Ba2 (left) and Ca2 (right) currents recorded from
oocytes expressing the K1C and K2-N Ca2 channel subunits with ei-
ther the L1 or the L2 subunit. Currents were recorded during voltage
steps of 2.5 s with a duration from 3100 mV to +10 mV. Traces
are scaled at the same size for comparison (Ca2 currents were
about 1/3 of the Ba2 currents [25]). B: (left) Ca2 currents re-
corded from oocytes injected with either the K1C+L1 or the K1C+L2
Ca2 channel subunits. Current traces from the two combinations
recorded during depolarisations of the same amplitude were super-
imposed and scaled at the same size for the purpose of comparison.
Depolarisations were applied from a holding potential of 380 mV
to 0, 10, 20 or 30 mV. In all cases, the inactivation process can be
described by a bi-exponential decay. B: (right) Voltage-dependency
of the fast (d1) and the slow (d2) time constant of inactivation.
Note that only d2 is changed by expression of the L2 subunit (n = 7
and 8 for L1 and L2, respectively)
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with the L1 subunit (around 20% of the residual current after
a depolarization of 2.5 s, see Fig. 2). All subsequent amino-
terminal deletions of the L2 subunit induced also a similar
acceleration of inactivation (see traces L2-TF2 and L2-TF3
and bar graph of Fig. 2), while the carboxy deletion (L2-
TF4) was without an e¡ect. Altogether, these data suggest
that a short sequence on the L2 subunit (V1, corresponding
to the lost segment of the L2-TF1 subunit) is fully responsible
for the slow Ca2-dependent inactivation recorded with the L2
subunit.
We have tested this idea by inserting di¡erent sequences of
the L2 subunit (corresponding to the deleted sequences of the
L2-TF1, -TF2, -TF3 subunits) in a N-terminal position of the
L1 subunit and tested their e¡ect on Ca2-dependent inactiva-
tion. Four chimeras were thus constructed, where V1, V1+C1,
V1+C1+V2 and V1+C1+V2+an insertion, only found in V2
from L2, replaced the homologous sequences in the L1 subunit
(chimera L2/L1-CH4, L2/L1-CH1, L2/L1-CH2, L2/L1-CH3, re-
spectively). A ¢fth chimera, L1/L2-CH5, was also constructed
by replacing the V1 sequence of the L2 subunit by the corre-
sponding sequence of L1 (see Fig. 3 for constructions). All
these chimeras were co-expressed with the K1C subunits in
Xenopus oocytes and their e¡ects on Ca2-dependent inacti-
vation were tested. The results are displayed in Fig. 3. Inter-
estingly, all these chimera (CH3, CH2, CH1 and CH4) dis-
played a slow Ca2-dependent inactivation, con¢rming that
the acceleration of inactivation observed with the deleted
forms of the L2 subunit was indeed due to the removal of
an inhibitory sequence present in L2. L2/L1-CH4, the chimera
with the smallest sequence of L2 (the ¢rst 16 amino acids of
L2), has a slow Ca2-dependent inactivation (around 40% of
the residual current after a 2.5 s long depolarization to +10
mV) and de¢ned the minimum sequence for this e¡ect. The
reverse chimera, L1/L2-CH5 (V1 sequence of L1 replacing V1
of L2) has a fast inactivation comparable to L2-TF1, L1-TF1
or L1 and con¢rms the lack of other regulating regions in the
amino-terminal end of L1.
4. Discussion
We have recorded Ba2 and Ca2 currents after expression
of K1C L-type Ca2 channels in Xenopus oocytes. While inac-
tivation kinetics of Ba2 currents could be described by a
single exponential component, a fast and a slow component
of inactivation were necessary to account for the current ki-
netics recorded in the presence of Ca2. These two compo-
nents were clearly Ca2-dependent since they were absent in
the presence of Ba2 and clearly faster (at least by a factor
two at +10 mV) than the inactivation time constant of the
Ba2 currents. We show here that di¡erent Ca2 current ki-
netics can be recorded by assembly of the L-type K1C Ca2
channel subunit with various ancillary L subunits. Kinetic
modi¢cations mainly re£ect an increase of the slow time con-
stant of the Ca2-dependent inactivation. We have previously
shown that a short stretch of amino acids, located at the
amino-terminal end of the L2 subunit, was able to slow inac-
tivation when present [20]. In this work, using extended dele-
tions of the L1 and L2 subunits, we show that this sequence is
the only site responsible for the L2-speci¢c regulation of the
Ca2-dependent inactivation.
Up to now, Ca2-dependent inactivation of the L-type Ca2
channel was considered as a property of the K1C subunit, with
little or no in£uence of the L subunit [16,26]. Accordingly,
di¡erent sequences of the K1C subunit, including a putative
EF-hand Ca2 binding site, have been shown to be essential
for Ca2-dependent inactivation [18,19,27]. These sequences
are located at the carboxy-terminal end of the K1C subunit
and their transposition to other K1 subunits transferred
Ca2-dependent inactivation to channels usually resistant to
this type of inactivation. The fact that Ca2-dependent inac-
tivation can be speci¢cally modulated by the auxiliary L sub-
unit constitutes therefore an important ¢nding that could par-
tially explain the variability of the L-type Ca2 current
kinetics recorded on di¡erent muscular preparations. It is
Fig. 3. Current traces and Ca2-dependent inactivation recorded for
di¡erent chimeric L subunits. Left: schematic representation of dif-
ferent chimeric L subunits used in this work. In a ¢rst construct,
the missing sequence of the L1-TF3 subunit was replaced by the cor-
responding sequence of the L2 subunit (amino acids 1^212). In L2/
L1-CH2, L2/L1-CH1 and L2/L1-CH4, the participation of the L2 sub-
unit to the total sequence of the chimera was further reduced. L2/
L1-CH2 was deleted for an insert speci¢cally found in the second
variable domain of the L2 subunit (black box in the ¢gure, ami-
no acids 170^212). L2/L1-CH4 kept only the ¢rst 16 amino acids
from L2, the remaining sequence coming from L1. Middle: associ-
ated current traces recorded after expression of the L1, L2 or the dif-
ferent chimera in oocytes with the K1C subunit. Same recording con-
ditions as in Fig. 2. Right: average inactivation calculated for the
di¡erent chimeric L subunits. Inactivation was quanti¢ed as de-
scribed in Fig. 2 (residual current). n = 12, 4, 4, 8, 7, 4, 6 for L1, L2,
L2/L1-CH3, L2/L1-CH2, L2/L1-CH1, L2/L1-CH4 and L2/L1-CH5, re-
spectively.
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worth noting that alternative splice variants of the K1C sub-
unit have been isolated and are speci¢cally expressed in these
tissues [28^32]. However, although these isoforms can poten-
tially participate in the observed variability of the channel
properties, none of the functional studies performed yet evi-
denced any changes in the kinetics of the resulting Ca2 cur-
rent [26].
Interestingly, the N-terminal amino acid sequence respon-
sible for the slow inactivation of the L2 containing channels
has recently been shown to a¡ect the voltage-dependent in-
activation of the class E and class A Ca2 channels in a
similar manner [20,33], arguing for a general regulatory mech-
anism of inactivation by the L2 subunit. However, our results
on Ca2-dependent inactivation, as opposed to those of Ol-
cese et al. [33], de-emphasize the role of the amino-terminal
region of the L1 subunit in setting the rate of inactivation.
Rather, they suggest that association of the sole L interacting
domain (BID) of the L subunit is su⁄cient to speed the in-
activation while in the L2 subunit, a unique additional se-
quence is able to slow inactivation. Whether this unique se-
quence acted directly by functional interaction with the K1
subunit at a site similar or distinct of the K interaction domain
(AID) (K1 interacting site [15]) or indirectly, by inducing a
conformational rearrangement of the L subunit, remains to
be determined. Identi¢cation of amino acids involved in this
e¡ect, together with functional analysis of the intracellular
perfusion of this sequence (by peptide injection) on inactiva-
tion, will be critical to test these two hypothesis. The two
cysteines (at position 2 and 3 of the L2 subunit) involved in
the regulation of the voltage-dependent inactivation [34], con-
stitute undoubtedly a prime target for future experiments.
Recent work carried out by Walker et al. [35] identi¢ed
secondary sites of interaction between the K1 and the L4
subunit that plays a role in the regulation of channel inacti-
vation. These sites were located on the carboxy-terminal re-
gions of the L4 subunit and the K1A subunit. Whether such
second sites exist on the K1C subunit and a¡ects Ca2-depend-
ent inactivation is yet not known, but could also potentially
participate in the broad panel of Ca2-dependent inactivation
kinetics displayed by the L-type Ca2 channels in di¡erent
tissues.
Our L2 regulatory sequence is located at the amino-terminal
end of the protein and can be alternatively spliced to give rise
to at least three di¡erent L2 subunits (L2a, L2b and L2e) in rat,
rabbit or human [8]. Whether or not these di¡erent splice
variants have the same e¡ect on the kinetics of inactivation
of the L-type Ca2 current is not known, but one can predict
that they do not, since (i) homology between the L2b and the
L2a subunit is lower than with the L1 subunit in this particular
region and (ii) L2a and L2b have di¡erent e¡ects on voltage-
dependent inactivation [33]. Our results thus suggest that one
of the immediate functional impacts of these di¡erent splice
variants would be to ¢nally tune the level and kinetics of Ca2
entry into muscle cells. Regulation of inactivation by L sub-
units appears therefore to be a complex process involving
multiple sites and mechanisms.
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